Lucera Erick's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Aug 17, 2026
- Accession no.
- 0001697616-26-000002
- Filed
- Aug 17, 2026, 4:06 PM ET
- Trade date
- Aug 13, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $47.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lucera ErickCIK 0001697616 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | SSaleDisposed | −1,797 | $26.28 | −$47,225.16 | 119,766 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.